(Total Views: 634)
Posted On: 05/30/2020 12:51:22 PM
Post# of 156276
Re: Rubraquercus #36002
“Your comments enforce my concerns; why others continue getting trials and press.”
CYDY has two COVID trials currently enrolling in the U.S. and potential trials in Mexico and in the U.K. The company has also received plenty of press, including Fox News and many other news and online publications. So I’m not exactly sure what you’re concerned about.
Leronlimab is in the middle of blinded trials for COVID, so there isn’t much new information to discuss. When data from the 75 patient trial is released and its as promising as we believe it will be, CYDY will be back in the news.
CYDY has two COVID trials currently enrolling in the U.S. and potential trials in Mexico and in the U.K. The company has also received plenty of press, including Fox News and many other news and online publications. So I’m not exactly sure what you’re concerned about.
Leronlimab is in the middle of blinded trials for COVID, so there isn’t much new information to discuss. When data from the 75 patient trial is released and its as promising as we believe it will be, CYDY will be back in the news.
(2)
(0)
